Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection

Antiviral Therapy

Volumn 13, Issue 5, 2008, Pages 715-722

  McComsey, Grace A ^a,b,c   Libutti, Daniel E ^d   O'Riordan, MaryAnn ^b   Shelton, Jessica M ^d   Storer, Norma ^b   Ganz, Jason ^c   Jasper, John ^c   Harrill, Danielle ^a   Gerschenson, Mariana ^d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CYTOCHROME B; EMTRICITABINE; LAMIVUDINE; MITOCHONDRIAL DNA; MITOCHONDRIAL RNA; NUCLEAR RNA; NUCLEAR RNA L13; PROTEINASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE 6; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; THYMIDINE DERIVATIVE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE PROBE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEAN BODY WEIGHT; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL RNA DEPLETION; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADULT; AGED; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; DNA, MITOCHONDRIAL; FEMALE; HIV INFECTIONS; HIV-1; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; RNA;

EID: 49949117158     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Walker UA, Bickel M, Lütke Volksbeck SI, et al. Evidence of nucleoside analogue reverse transcriptase inhibitor-associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients. J Acquir Immune Defic Syndr 2002; 29:117-121.
2. Nolan D, Hammond E, Martin A, et al. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 2003; 17:1329-1338.
3. McComsey GA, Paulsen DM, Lonergan TJ, et al. Improvements in lipoatrophy, mitochondrial DNA content and adipose tissue apoptosis levels after replacement of stavudine with either abacavir or zidovudine. AIDS 2005; 19:15-23.
4. Gerschenson M, Shiramizu B, LiButti DE, Shikuma CM. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals. Antivir Ther 2005; 10 Suppl, 2:M83-M89.
5. Deniaud A, Brenner C, Kroemer G. Mitochondrial membrane permeabilization by HIV-1 Vpr. Mitochondrion 2004; 4:223-233.
6. Sabbah EN, Druillennec S, Morellet N, Bouaziz S, Kroemer G, Roques BP. Interaction between the HIV-1 protein Vpr and the adenine nucleotide translocator. Chem Biol Drug Des 2006; 67:145-154.
7. Nie Z, Bren GD, Vlahakis SR, et al. Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J Virol 2007; 81:6947-6956.
8. Kotler DP, Ionescu G, Johnson JA, et al. Studies of adipose tissue metabolism in human immunodeficiency virus-associated lipodystrophy. Clin Infect Dis 2003; 37 Suppl 2:S47-S51.
9. Grunfeld C, Tien P. Difficulties in understanding the metabolic complications of acquired immune deficiency syndrome. Clin Infect Dis 2003; 37 Suppl 2:S43-S46.
10. Kotler DP, Rosenbaum K, Wang J, Pierson RN. Studies fo body composition and fat distribution in HIV-infected and control subjects. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:228-237.
11. Van der Valk M, Gisolf EH, Reiss P and the Prometheus study group. Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection. AIDS 2001; 15:847-555.
12. Lichtenstein KA. Redefining lipodystrophy syndrome: risks and impact on clinical decision making. J Acquir Immune Defic Syndr 2005; 39:395-400.
13. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
14. Shiramizu B, Shikuma. KM, Kamemoto L, et al. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 2003; 32:370-374.
15. Cossarizza A, Pinti M, Moretti L, et al. Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. J Infect Dis 2002; 185:299-305.
16. Galluzzi L, Pinti M, Guaraldi G, et al. Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy. Antivir Ther 2005; 10 Suppl 2:M91-M99.
17. Galluzzi L, Pinti M, Troiano L, et al. Changes in mitochondrial RNA production in cells treated with nucleoside analogues. Antivir Ther 2005; 10:191-195.
18. Kim MJ, Jardel C, Barthélémy C, et al. Mitochondrial DNA content: an inaccurate biomarker of mitochondrial 1 alteration in HIV-related lipodytrosphy. Antimicrob Agents Chemother 2008; 52:1670-1676.
19. d'Amati G, Lewis W. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells. Lab Invest 1994; 71:879-884.
20. Mallon PW, Unemori P, Sedwell R, et al. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J Infect Dis 2005; 191:1686-1696.
21. Toshiyuki M, Mieko G, Noriaki H, et al. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy. J Med Virol 2003; 70:497-505.
22. de Mendoza C, de Ronde A, Smolders K, et al. Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy. AIDS Res Hum Retroviruses 2004; 20:271-273.
23. Barazzoni R, Short KR, Nair KS. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem 2000; 275:3343-3347.
24. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005; 54:8-14.
25. McComsey GA, Walker UA. Mitochondria and HIV lipoatrophy. Mitochondrion 2004; 4:111-118.
26. Lund KC, Peterson LL, Wallace KB. Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs. Antimicrob Agents Chemother 2007; 51:2531-2539.
27. Barret B, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 2003; 17:1769-1785.
28. Lopez S, Miro O, Martinez E, et al. Mitochondrial effects of antiretroviral therapies in asymptornatic patients. Antivir Ther 2004; 9:47-55.
29. Miro O, Lopez S, Rodriguez de la Concepcion M, et al. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. J Acquir Immune Defic Syndr 2004; 37:1550-1555.
30. McComsey G, Bai R, Maa J-F, Seekins D, Wong L-J. Extensive investigations of mitochondrial DNA genome in lipoatropy: beyond mtDNA depletion. J Acquir Immune Defic Syndr 2005; 39:181-188.
31. Sluse FE, Jarmuszkiewicz W, Navet R, Douette P, Mathy G, Sluse-Goffart CM. Mitochondrial UCPs: new insights into regulation and impact. Biochim Biophys Acta 2006; 1757:480-485.
32. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350:664-671.
33. FRAM Study Investigators. Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr 2005; 40:121-131.
34. From the Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Fat distribution in women with HIV infection. J Acquir Immune Defic Syndr 2006; 42:562-571.